Cargando…
The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies
Cancer remains an elusive, highly complex disease and a global burden. Constant change by acquired mutations and metabolic reprogramming contribute to the high inter- and intratumor heterogeneity of malignant cells, their selective growth advantage, and their resistance to anticancer therapies. In t...
Autores principales: | Jaganjac, Morana, Milkovic, Lidija, Sunjic, Suzana Borovic, Zarkovic, Neven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699519/ https://www.ncbi.nlm.nih.gov/pubmed/33228209 http://dx.doi.org/10.3390/antiox9111151 |
Ejemplares similares
-
Utilizing Iron for Targeted Lipid Peroxidation as Anticancer Option of Integrative Biomedicine: A Short Review of Nanosystems Containing Iron
por: Jaganjac, Morana, et al.
Publicado: (2020) -
Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response
por: Gall Trošelj, Koraljka, et al.
Publicado: (2022) -
Editorial on Anticancer Antioxidants
por: Sunjic, Suzana Borovic, et al.
Publicado: (2021) -
Short Survey on the Protein Modifications in Plasma during SARS-CoV-2 Infection
por: Gęgotek, Agnieszka, et al.
Publicado: (2023) -
The 4-Hydroxynonenal–Protein Adducts and Their Biological Relevance: Are Some Proteins Preferred Targets?
por: Milkovic, Lidija, et al.
Publicado: (2023)